News and Community

Fibrodysplasia Ossificans Progressiva Treatment, Fop Clinical Trial, Phase 2 Clinical Study, Rare Disease Therapeutics, Zilurgisertib

June 15, 2026

Mirum and Incyte Announce Phase 2 Results for FOP Treatment Candidate